Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent 5-Fluorouracil (5-FU)
- PMID: 22930839
Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent 5-Fluorouracil (5-FU)
Abstract
Beneficial bacteria (probiotics) and probiotic-derived factors have the potential to ameliorate disorders of the intestine. The aim of this study was to compare live Streptococcus thermophilus TH-4 (TH-4), dead TH-4 and TH-4 supernatant in rats treated with 5-Fluorouracil. Rats were randomly allocated to five treatment groups (n = 8–10): Saline + Water; 5-FU + Skim Milk; 5-FU+ Live TH-4; 5-FU + Supernatant TH-4; and 5-FU + Dead TH-4.5-FU (150 mg.kg-1) was administered by a single intraperitoneal injection on day zero; animals were killed on day four. Treatments were administered daily from days -2 to +3 via oro-gastric gavage. Metabolic parameters were measured daily. Blood was obtained by cardiac puncture, and intestinal tissues removed for quantitative and qualitative histological assessment, including: villus height and area; crypt depth and area, mitotic count and crypt fission;biochemical determination of sucrase and myeloperoxidase (MPO)activity; and disease severity scoring. One-way ANOVA statistical analyses were conducted for the majority of outcome measures. Live TH-4 significantly reduced disease severity score by 13% (p< 0.05), and partially normalized mitotic counts compared with 5-FU + Skim Milk controls. Live and Supernatant TH-4 reduced crypt fission by 69% and 48% (p < 0.05), respectively, compared to 5-FU + Skim Milk controls. No significant differences (p > 0.05) in the occurrence of bacteraemia were evident across all groups. Live TH-4 partially normalized mitotic count and histological severity score in 5-FU treated rats. The inhibitory effect of live TH-4 and TH-4 Supernatant on crypt fission suggests therapeutic utility in the prevention of disorders characterized by increased crypt fission,such as colorectal carcinoma.
Comment in
-
Gut microbiome and intestinal mucositis: a new challenge for researchers.Cancer Biol Ther. 2009 Mar 15;8(6):512-3. doi: 10.4161/cbt.8.6.7852. Epub 2009 Mar 15. Cancer Biol Ther. 2009. PMID: 19411862 No abstract available.
Similar articles
-
Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU).Cancer Biol Ther. 2009 Mar 15;8(6):505-11. Epub 2009 Mar 15. Cancer Biol Ther. 2009. PMID: 19305160
-
Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis.Scand J Gastroenterol. 2013 Aug;48(8):959-68. doi: 10.3109/00365521.2013.812142. Scand J Gastroenterol. 2013. PMID: 23865592
-
Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.Cancer Biol Ther. 2011 Apr 1;11(7):671-7. doi: 10.4161/cbt.11.7.14896. Epub 2011 Apr 1. Cancer Biol Ther. 2011. PMID: 21307648
-
Possible cytoprotective mechanisms of oxytocin against 5-fluorouracil-induced gastrointestinal mucositis.Mol Biol Rep. 2022 May;49(5):4055-4059. doi: 10.1007/s11033-022-07384-3. Epub 2022 Apr 26. Mol Biol Rep. 2022. PMID: 35474056 Review.
-
The Impact of Probiotics on Intestinal Mucositis during Chemotherapy for Colorectal Cancer: A Comprehensive Review of Animal Studies.Int J Mol Sci. 2021 Aug 28;22(17):9347. doi: 10.3390/ijms22179347. Int J Mol Sci. 2021. PMID: 34502251 Free PMC article. Review.
Cited by
-
Elucidating the effect of anti-biofilm activity of bioactive compounds extracted from plants.J Biosci. 2019 Jun;44(2):52. J Biosci. 2019. PMID: 31180065 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous